Our research comprises basic and translational programs aiming to elucidate the molecular immunometabolic mechanisms of intracellular communication that drive neurologic disorders (ranging from autoimmune and degenerative diseases to cancer).
details
We are continuously looking for new talents. If you are passionate about scientific research and innovation, motivated, ambitious and driven, we want you to be part of our team.
details101 on #MultipleSclerosis - Clinical Management, Therapeutic Strategies, and Research Trends. By one of the pioneers in the field (who is also my friend and lifetime mentor) - @weinerlabhms
I recorded my lecture today for the Harvard CME Course on MS to be held on September 9th. Here's the link if you would like to participate: https://cmecatalog.hms.harvard.edu/multiple-sclerosis-comprehensive-update
It’s out! Our @NatureNeuro paper introducing an iPSC-Microglia protocol and screening platform that identifies modulators of microglia functions and states: “A CRISPRi/a platform in iPSC-derived microglia uncovers regulators of disease states.” https://www.nature.com/articles/s41593-022-01131-4
🧵(1/15)
